Prof. Paul O’Byrne talks about the new data from the 20-year-old START trial, which evaluated the benefits of early ICS introduction in patients with mild and mildest forms of asthma, and considers benefits and potential downsides of this approach in light of some new information.
Prof. Francois Caron continues the discussion on smoking cessation and explains the potential use of cytisine and e-cigarettes.
Prof. Jonathan Sherbino reviews the benefits and downsides of aggressive BP lowering strategies in patients with intracranial hemorrhage on the basis of the ATACH-2 trial.
Prof. Zainab Samaan explains what the EAGLES trial tells us about smoking cessation in patients with psychiatric disorders.
Prof. Sanjit S. Jolly explains what we’ve learned about thrombectomy in MI from the TOTAL trial and shares advice for noncardiologists approaching STEMI and NSTEMI.
Prof. Francois Caron explains how to approach a patient trying to quit smoking and what we have learned from the latest large-scale RCT about smoking cessation.
Prof. Paul O’Byrne comments on the most recent studies confirming the safety of long-acting ß2-agonists added to inhaled corticosteroids in patients with asthma.
Prof. P.J. Devereaux guides us through managing patients with perioperative myocardial injury and sheds light on the future of preventing peri-op cardiac events.
Prof. Andrew McIvor considers choices among bronchodilators and inhaled corticosteroids in patients with chronic obstructive pulmonary disease.
Prof. Maria Tiboni shares advice on how to achieve a multidisciplinary approach to bariatric surgery, comments on the prevalence of surgery, and describes the ideal candidate.
English
Polski
Español
українська